Ceftiofur, a cephalosporin antimicrobial, was used systematically in Canadian hatcheries 25 for many years to prevent early mortality in chicks leading to a high prevalence of 26 cephalosporin resistance in Escherichia coli in chickens. Preventive use of ceftiofur in 27 hatcheries ceased in 2014. We examined the effect of ceftiofur cessation and replacement 28 with lincomycin-spectinomycin at the hatchery on the proportion of E. coli positive for 29 extended-spectrum β-lactamase (ESBL) and AmpC β-lactamase related genes, and on the 30 Antimicrobial resistance is a global problem. The antimicrobial ceftiofur has been used 46 worldwide for disease prevention in poultry production resulting in a greatly increased 47 resistance to this antimicrobial important in poultry and human medicine. Our study 48 examines the impact of ceftiofur cessation and its replacement with the antimicrobial 49 combination lincomycin-spectinomycin, a common practice in the industry. Our study 50 demonstrated a decrease in ceftiofur resistance after the cessation of its use, although the 51 resistance genes remain ubiquitous in all phases of poultry production, showing that 52 poultry remains a reservoir for ceftiofur resistance and requiring continued vigilance. We 53 also observed a decrease in multidrug resistance after cessation of ceftiofur although the 54 contrary finding following use of lincomycin-spectinomycin indicates that the use of 55 these antimicrobials should be questioned. Reduced resistance to ceftiofur in poultry may 56 translate to better treatment efficacy, decreased morbidity, mortality, duration and cost of 57 hospitalization in humans. 58
Introduction 59
One of the most important causes of early mortality in broiler chick is omphalitis, mostly 60 caused by avian pathogenic E. coli (APEC), a subgroup of extra-intestinal pathogenic E. 61 coli (ExPEC) (1, 2). Ceftiofur, a third generation cephalosporin antimicrobial, has been 62 administered for over 15 years either in ovo or by subcutaneous injection at the hatchery, 63 in order to reduce early chick mortality in many countries (3) Consequently, an increased 64 prevalence of extended-spectrum β-lactamase (ESBL) and AmpC β-lactamase producing 65
Escherichia coli has been reported worldwide (4-7), resulting in an increased extended 66 meconium samples (4 meconium samples each allowed the production of two different 133 broiler flocks, making a total of 24 broiler flocks with 20 meconium samples) and 20 134 composite fecal samples of broiler flocks (traceability to the breeders was lost for 4 lots) 135 were selected. In 2015, a total of 24 samples from 8 breeder flocks, with corresponding 136 meconium and composite fecal samples from 14 broiler chicken flocks for which no in 137 ovo antimicrobials were administered and 16 flocks for which lincomycin-spectinomycin 138 was administered in ovo, were taken. 139
Colony isolation of Escherichia coli 140
From the frozen samples, two different isolation protocols were used to obtain an 141 indicator E. coli isolate collection and a potential ESBL/AmpC-producing isolate 142 collection. 
b. Potential ESBL/AmpC-producing isolate collection 152
We used the protocol described previously by Agersø and colleagues with some 153 modifications (18, 19) . A volume of 50 μl of each thawed sample was inoculated in 5 ml 154 of peptone water containing 1 mg/ml ceftriaxone (20) . After incubation at 37 °C 155 overnight, cultures were streaked on MacConkey agar plates with 1 mg/ml ceftriaxone. 156
After another overnight incubation at 37 °C, 5 colonies were selected (preferably lactose 157 +) and inoculated on MacConkey agar containing 1 mg/ml ceftriaxone overnight. Five 158 well isolated colonies on agar were placed in LB culture medium and incubated overnight 159 at 37 °C. Finally, 750 μL of each bacterial suspension was mixed with 750 μL of 30% 160 glycerol and frozen at -80 °C. 161
DNA extraction and uidA PCR 162
For each isolate, DNA was extracted from the overnight culture in LB medium. DNA 163 templates were prepared from the samples by boiled cell lysis for examination by PCR, 164 as described previously by Maluta et al. (21) Magiorakos et al. (27) . In order to more precisely compare the level of 199 MDR between groups, the level of multi-drug resistance for each sample was classified 200 from 0 to 10, representing the number of antimicrobial classes to which the sample was 201 non-susceptible. Before the cessation of Ceftiofur, the proportion of samples with E. coli positive for 213 bla CMY-2 was very high for the meconium (90%), decreasing to 60% in the feces of 214 broilers at the end of fattening, and to 0% in breeders (Table 1) . Similarly, the proportion 215 of samples with E.coli positive for bla CTX-M was higher for the meconium (20%) than in 216 broilers (5%) and in breeders (0%). Interestingly, following cessation of ceftiofur and 217 without the in ovo administration of lincomycin-spectinomycin, a decrease in the 218 proportion of samples with E. coli positive for bla CMY-2 was observed in the meconium 219 and broiler feces, being significant (p=0,002) only for the meconium. The same trend was 220 observed when comparing the proportion of samples with E. coli positive for bla CTX-M are ubiquitous in most examined samples, we wished to determine the effect of 293 lincomycin-spectinomycin administration on the non-susceptibility of these isolates to 294 antimicrobials of the different categories and on the level of MDR. As expected, with 295 almost 100% of isolates positive for bla CMY-2 gene, resistance to penicillins with and 296 without β-lactamases inhibitors, cephalosporins of third generation, and cephamycin was 297 almost 100%, irrespective of the antimicrobial used at the hatchery. There was no 298 difference in the proportion of samples harboring bla CMY-2 -positive E. coli non-299 susceptible for any of the six other antimicrobial classes in meconium or broiler feces 300 between flocks before and after cessation of in ovo administration of ceftiofur when there 301 was no replacement with lincomycin-spectinomycin, except for the non-susceptibility to 302 trimethoprim-sulphamethoxazole in broiler feces where a significant decrease was 303 observed following the ceftiofur cessation (p= 0,001). 304
On the other hand, there were a significantly greater proportion of samples harboring 305 bla CMY-2 -positive E. coli non-susceptible to streptomycin, trimethoprim-306 sulphamethoxazole, chloramphenicol, and tetracyclines in broiler feces when lincomycin-307 spectinomycin was administered in ovo than when no antimicrobial was used following 308 cessation of administration of ceftiofur (Table 3) . The same trend could be seen in the 309 meconium, although the results were not statistically different, with the exception of 310 spectinomycin. For many of these antimicrobials, a significantly greater proportion of 311 samples harboring bla CMY-2 -positive non-susceptible E. coli in meconium was observed 312 when lincomycin-spectinomycin was administered in ovo than prior to cessation of 313 administration of ceftiofur. A similar trend was observed in the broiler feces but was only 314 significant for spectinomycin. Finally, neither the cessation of in ovo administration of 315 ceftiofur nor replacement with lincomycin-spectinomycin affected the proportion of 316 samples harboring bla CMY-2 -positive E. coli non-susceptible to fluoroquinolones 317 (nalidixic acid and ciprofloxacin) and macrolides (azithromycin). There was a very low 318
proportion of non-susceptibility to these antimicrobials in isolates of the potential 319 ESBL/AmpC-producing E. coli collection (Table 4) showed only β-lactam non-susceptibility (non-susceptibility being to 4 or more classes) 340 (Table 4) resistance to extended spectrum cephalosporins was observed (4, 9, 12). Nevertheless, we 354 did not observe an effect in the broilers, as was the case in the previous studies (7). In 355 addition, the substitution of ceftiofur with lincomycin-spectinomycin in the broiler 356 hatchery did not have a significant impact on the presence of bla CMY-2 or bla CTX-M in this 357 collection, reinforcing the idea that these genes were selected mainly due to the use of 358 ceftiofur. When we used a more sensitive approach of enrichment with ceftriaxone, we 359 found that almost all samples, irrespective of the production phase, harbored isolates 360 positive for the ESBL/AmpC resistance genes, mostly bla CMY-2, before the cessation of 361 the use of ceftiofur, and this was not affected by the cessation, at least in the first year 362 after it occurred. 363
We observed E. coli positive for bla CTX-M across all the poultry production chain, 364
suggesting that this gene is more prevalent in Canadian flocks than previously reported 365 (6). Our results following ceftriaxone enrichment demonstrated that cephalosporin 366 resistance genes were still present among the population but that the prevalence was 367 probably lower in the flocks following the cessation of use of ceftiofur. The lower 368 prevalence of bla CTX-M with respect to bla CMY-2 in our study in contrast to the lower 369 prevalence of bla CMY-2 reported in Europe (5) could be due to the presence of different 370 plasmids containing bla CTX-M in Europe such as IncN, IncI, IncL/M and IncK (8). 371
Nevertheless, a more recent study in Europe showed a higher proportion of bla CMY-2 (28). 372
The difference in relative predominance of the bla CTX-M and bla CMY-2 .genes could also be 373 explained in part by differences in geographical distribution of these genes (7). isolates with non-susceptibility to at least 6 classes whereas those which had received 405 ceftiofur before its cessation or no antimicrobial in ovo harbored isolates non-susceptible 406 to only 4 classes, the gene bla CMY-2 conferring non-susceptibility to the 4 classes of β-407 lactams. These results suggested that there may be a co-selection phenomenon when 408 using lincomycin-spectinomycin, which would explain the high MDR for this group. Furthermore, other plasmids such as IncFIB had a positive association with IncA/C 435 whereas IncI1 plasmid had a negative association with these plasmids (11). The presence 436 of such plasmids in our study may explain why multidrug-resistant bacteria were selected 437 when using lincomycin-spectinomycin at the hatchery. Studies in Japan and Netherlands 438 also found IncA/C plasmids harboring bla CMY-2 and resistance to non β-lactam 439 antimicrobial (28, 33). The plasmids selected in our study may have contained bla CMY-2 440 genes and other resistance genes. Alternatively, certain clonal lineages may harbor one 441 plasmid with the bla CMY-2 genes concomitantly with a second plasmid conferring 442 resistance to non β-lactam antimicrobials. Plasmids of several incompatibility groups, 443 such as as IncIγ, IncB/O, IncFIB, IncFIC and IncI1, have already been reported to contain 444 bla CMY-2 genes alone, but not resistance to non β-lactam antimicrobials (11, 33) . 445
Horizontal and vertical transmission of bla CMY-2 has already been reported (19), thus 446 further testing is needed to evaluate if vertical transmission of bla CMY-2 and bla CTX-M 447 occurs between the breeders and broilers of our study. 448
We observed a significant decrease in non-susceptibility to trimethoprim-449 sulphamethoxazole in the broiler feces for the flocks which did not receive any 450 antimicrobial in ovo following the cessation of ceftiofur, thus demonstrating the potential 451 for a positive cessation effect for this class of antimicrobials. This decrease could be 452 explained by a selective disadvantage of bla CMY-2 on certain plasmids at the animal level 453 when ceftiofur is stopped and no antimicrobial is used subsequently (28). Furthermore, 454 resistance to phenicols and tetracyclines were lower, although not significantly, for these 455 same flocks, showing a beneficial effect with respect to the prevalence of MDR. 456
Nevertheless, no significant differences were seen for the meconium and broiler feces 457 between flocks receiving ceftiofur prior to its cessation and flocks when ceftiofur is 458 stopped and no antimicrobial is used subsequently with respect to non-susceptibility to 459 gentamicin, spectinomycin, sulfisoxazole, tetracyclines and chloramphenicol, which 460 suggests that resistance to these antimicrobials is mainly due to the use of lincomycin-461 spectinomycin. However, antimicrobials received during rearing may also affect the 462 variation in the prevalence of non-susceptibility to these antimicrobials. If broiler flocks 463 not receiving antimicrobials in ovo have lower level of resistance to certain 464 antimicrobials (such as trimethoprim-sulphamethoxazole), stopping antimicrobials at the 465 hatchery could lead to clinically more effective antimicrobial treatments during fattening. 466
We observed very little non-susceptibility to the fluoroquinolones (nalidixic acid and 467 ciprofloxacin) and macrolids (azithromycin) in E. coli isolates obtained following 468 ceftriaxone enrichment. This result was expected as these classes of antimicrobial agent 469
were not approved for use in poultry in Canada during the years of our study, during 470 which time ceftiofur, bacitracin, virginiamycin, avilamycin, and lincomycin-471 spectinomycin were the most commonly used antimicrobials(3). In addition, ceftriaxone 472 enrichment is not a selective method for detection of quinolones or macrolids resistance. 473
Finally, resistance to quinolones is mainly due to the acquisition of chromosomal 474 mutations rather than to resistance genes present on plasmids as is the case for 475 ESBL/AmpC production (34). 476
Overall, our results demonstrate a decrease in the prevalence of cephalosporin-resistant 477 E. coli harboring bla CMY-2 and bla CTX-M after the ceftiofur cessation and replacement with 478 lincomycin-spectinomycin. No differences were seen in the proportion of bla SHV , bla OXA 479 and bla TEM . On other hand, when samples were examined using the more sensitive 480 ceftriaxone-enrichment, 99% of samples were shown to harbor cephalosporin-resistant E. spectinomycin, which is a concern for public health. 
